SEC Filing Timeline
Recent News (Finnhub)
Novavax (NVAX) Stock Could Be Above Fair Value As Plague Fears Fade
Novavax: Sell The False Plague Breakout
Should Novavax’s Headline-Driven Volatility Around Russia Health Scare Require Action From NVAX Investors?
Novavax: Vaccine Maker Sees Momentum In 2026, But Growth Story Holds Fundamental Risks
'Russia Denies Report of Second Case of Illness in Siberia' - Bloomberg
Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility
Transcript: Novavax Q2 2026 Earnings Conference Call
Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare.